Reports

Designer Cytokines: Targeting Actions to Cells of Choice

See allHide authors and affiliations

Science  24 Nov 1995:
Vol. 270, Issue 5240, pp. 1351-1353
DOI: 10.1126/science.270.5240.1351

Abstract

Some growth factors are therapeutically useful partly because restricted expression of their receptors limits their action to particular cell types. However, no unique stimulatory factor is known for many clinically relevant cell types, such as CD34+ hematopoietic stem cells. Here, soluble α receptor (Rα) components for interleukin-6 (IL-6) and ciliary neurotrophic factor (CNTF) were targeted in an active form to cells expressing surface markers such as CD34 or CD45, thereby rendering those cells responsive to IL-6 or CNTF. The targeting of Rα components may provide the means to create “designer” cytokines that activate a desired cell type expressing a specific cell surface marker.